peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson Peptides are starting to move back into the conversation., After years of restriction under the FDAs 503A Category 2 list, were now seeing momentum toward re evaluation and potential reintroduction Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy FDA Peptide Reclassification 2026: What Researchers Want FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law